Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France

Michael Levy; Morgan Recher; Hervé Hubert; Etienne Javouhey; Olivier Fléchelles; Stéphane Leteurtre; François Angoulvant

doi:10.1001/jama.2021.23262

Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in France

JAMA. 2022 Jan 18;327(3):281-283. doi: 10.1001/jama.2021.23262.

Authors

Michael Levy¹, Morgan Recher², Hervé Hubert², Etienne Javouhey³, Olivier Fléchelles⁴, Stéphane Leteurtre², François Angoulvant⁵

Affiliations

¹ Pediatric Intensive Care Unit, Hôpital Universitaire Robert-Debré, Paris, France.
² ULR 2694-METRICS, Université de Lille, Lille, France.
³ Pediatric Intensive Care Unit, Hôpital Femme Mère Enfant, Lyon, France.
⁴ Pediatric Intensive Care Unit, Centre Hospitalier Universitaire de Martinique, Fort-de-France, France.
⁵ Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Hôpital Universitaire Robert-Debré, Paris, France.

Abstract

This study examines the risk of multisystem inflammatory syndrome in children among those aged 12 years or older by COVID-19 vaccination status during September 2021 and October 2021 in France.

MeSH terms

Adolescent
COVID-19 / complications*
COVID-19 / epidemiology
COVID-19 / immunology
COVID-19 Vaccines / administration & dosage*
COVID-19 Vaccines / immunology
Female
France / epidemiology
Humans
Male
SARS-CoV-2 / immunology
Systemic Inflammatory Response Syndrome / epidemiology*
Vaccination Coverage / statistics & numerical data*

Substances

COVID-19 Vaccines

Supplementary concepts

pediatric multisystem inflammatory disease, COVID-19 related